SHARE TEXT
 
Peiman Hematti, MD close
6SrNJEnsIXs
Peiman Hematti, MD
 

New Patients

Contact the Welcome Center for help choosing a new primary care doctor.

For Referring Physicians

How to refer a patient

Peiman Hematti, MD Print Friendly Page

Faculty, University of Wisconsin School of Medicine and Public Health

Dr. Peiman Hematti joined the Section of Hematology/Bone Marrow Transplantation at the University of Wisconsin-Madison in July 2004 as an Assistant Professor in the Department of Medicine. Dr. Hematti has completed a combined Internal Medicine/Pediatrics residency at the Cleveland Clinic Foundation and then Hematology fellowship at the National Heart, Lung and Blood Institute at the National Institutes of Health. His clinical interests are in inpatient care of hematopoietic stem cell transplant patients. He is the director of the clinical hematopoietic cell processing laboratory, and in that capacity oversees all the peripheral blood stem cell collections from the patients and processing of their products.

Specialties

Clinics

UW Carbone Cancer Center
(608) 265-1700 | (800) 323-8942 | Map
UW Carbone Cancer Center
(608) 265-1700 | (800) 323-8942 | Map

UW School of Medicine and Public Health

Department of Medicine
Department of Pediatrics

Professional Certifications and Education

Board Certification Hematology
Internal Medicine
Pediatrics
Fellowship National Institutes of Health, Bethesda, MD
Residency Cleveland Clinic Foundation, Cleveland, OH
Internship Cleveland Clinic Foundation, Cleveland, OH
Medical School Tehran University of Medical Sciences, Tehran, Iran

Medical interpreters are available to help patients communicate with hospital and clinic staff. For more information, please contact interpreter services at (608) 262-9000.
Research

Dr. Hematti runs an active basic research lab with the goal of developing methods for ex vivo generation and expansion of hematopoietic stem cells. His clinical research interest is in using novel mobilization agents for collection of peripheral blood stem cells.


PubMed Articles
Parikh SH Satwani P Ahn KW Sahr NA Fretham C Abraham AA Agrawal V Auletta JJ Abdel-Azim H Copelan E Diaz MA Dvorak CC Frangoul HA Freytes CO Gadalla SM Gale RP George B Gergis U Hashmi S Hematti P Hildebrandt GC Keating AK Lazarus HM Myers KC Olsson RF Prestidge T Rotz SJ Savani BN Shereck EB Williams KM Wirk B Pasquini MC Loren AW Survival Trends in Infants Undergoing Allogeneic Hematopoietic Cell Transplant. JAMA Pediatr . 2019 Mar 18;:e190081
[PubMed ID: 30882883]
Dhakal B Pagenkopf A Umair Mushtaq M Cunningham AM Flietner E Morrow Z Papadas A Hope C Leith C Hematti P Hari P Callander NS Asimakopoulos F Versican proteolysis predicts immune effector infiltration and post-transplant survival in myeloma. Leuk Lymphoma . 2019 Mar 8;:1-5
[PubMed ID: 30845856]
Inamoto Y Petri�ek I Burns L Chhabra S DeFilipp Z Hematti P Rovó A Schears R Shah A Agrawal V Al-Khinji A Ahmed I Ali A Aljurf M Alkhateeb H Beitinjaneh A Bhatt N Buchbinder D Byrne M Callander N Fahnehjelm K Farhadfar N Gale RP Ganguly S Hildebrandt GC Horn E Jakubowski A Kamble RT Law J Lee C Nathan S Penack O Pingali R Prasad P Pulanic D Rotz S Shreenivas A Steinberg A Tabbara K Tichelli A Wirk B Yared J Basak GW Battiwalla M Duarte R Savani BN Flowers MED Shaw BE Valdés-Sanz N Correction: Non-GVHD ocular complications after hematopoietic cell transplantation: expert review from the Late Effects and Quality of Life Working Committee of the CIBMTR and Transplant Complications Working Party of the EBMT. Bone Marrow Transplant . 2019 Feb 27;
[PubMed ID: 30809032]
Inamoto Y Petri�ek I Burns L Chhabra S DeFilipp Z Hematti P Rovó A Schears R Shah A Agrawal V Al-Khinji A Ahmed I Ali A Aljurf M Alkhateeb H Beitinjaneh A Bhatt N Buchbinder D Byrne M Callander N Fahnehjelm K Farhadfar N Gale RP Ganguly S Hildebrandt GC Horn E Jakubowski A Kamble RT Law J Lee C Nathan S Penack O Pingali R Prasad P Pulanic D Rotz S Shreenivas A Steinberg A Tabbara K Tichelli A Wirk B Yared J Basak GW Battiwalla M Duarte R Savani BN Flowers MED Shaw BE Valdés-Sanz N Non-GVHD ocular complications after hematopoietic cell transplantation: expert review from the Late Effects and Quality of Life Working Committee of the CIBMTR and Transplant Complications Working Party of the EBMT. Bone Marrow Transplant . 2019 Feb 27;
[PubMed ID: 30531955]
Chamberlain CS Clements AEB Kink JA Choi U Baer GS Halanski MA Hematti P Vanderby R Extracellular Vesicle-Educated Macrophages Promote Early Achilles Tendon Healing. Stem Cells . 2019 Feb 5;
[PubMed ID: 30720911]
Prokopishyn NL Logan BR Kiefer DM Sees JA Chitphakdithai P Ahmed IA Anderlini PN Beitinjaneh AM Bredeson C Cerny J Chhabra S Daly A Diaz MA Farhadfar N Frangoul HA Ganguly S Gastineau DA Gergis U Hale GA Hematti P Kamble RT Kasow KA Lazarus HM Liesveld JL Murthy HS Norkin M Olsson RF Papari M Savani BN Szer J Waller EK Wirk B Yared JA Pulsipher MA Shah NN Switzer GE O'Donnell PV Confer DL Shaw BE The Concentration of Total Nucleated Cells in Harvested Bone Marrow for Transplantation Has Decreased over Time. Biol Blood Marrow Transplant . 2019 Feb 2;
[PubMed ID: 30716454]
Norkin M Shaw BE Brazauskas R Tecca HR Leather HL Gea-Banacloche J T Kamble R DeFilipp Z Jacobsohn DA Ringden O Inamoto Y A Kasow K Buchbinder D Shaw P Hematti P Schears R Badawy SM Lazarus HM Bhatt N Horn B Chhabra S M Page K Hamilton B Hildebrandt GC Yared JA Agrawal V M Beitinjaneh A Majhail N Kindwall-Keller T Olsson RF Schoemans H Gale RP Ganguly S A Ahmed I Schouten HC L Liesveld J Khera N Steinberg A Shah AJ Solh M Marks DI Rybka W Aljurf M Dietz AC Gergis U George B Seo S Flowers MED Battiwalla M Savani BN Riches ML Wingard JR Characteristics of Late Fatal Infections after Allogeneic Hematopoietic Cell Transplantation. Biol Blood Marrow Transplant . 2019 Feb;25(2):362-368
[PubMed ID: 30287390]
Chhabra S Liu Y Hemmer MT Costa L Pidala JA Couriel DR Alousi AM Majhail NS Stuart RK Kim D Ringden O Urbano-Ispizua A Saad A Savani BN Cooper B Marks DI Socie G Schouten HC Schoemans H Abdel-Azim H Yared J Cahn JY Wagner J Antin JH Verdonck LF Lehmann L Aljurf MD MacMillan ML Litzow MR Solh MM Qayed M Hematti P Kamble RT Vij R Hayashi RJ Gale RP Martino R Seo S Hashmi SK Nishihori T Teshima T Gergis U Inamoto Y Spellman SR Arora M Hamilton BK Comparative Analysis of Calcineurin Inhibitor-Based Methotrexate and Mycophenolate Mofetil-Containing Regimens for Prevention of Graft-versus-Host Disease after Reduced-Intensity Conditioning Allogeneic Transplantation. Biol Blood Marrow Transplant . 2019 Jan;25(1):73-85
[PubMed ID: 30153491]
Inamoto Y Petri�ek I Burns L Chhabra S DeFilipp Z Hematti P Rovó A Schears R Shah A Agrawal V Ahmed A Ahmed I Ali A Aljurf M Alkhateeb H Beitinjaneh A Bhatt N Buchbinder D Byrne M Callander N Fahnehjelm K Farhadfar N Gale RP Ganguly S Hashmi S Hildebrandt GC Horn E Jakubowski A Kamble RT Law J Lee C Nathan S Penack O Pingali R Prasad P Pulanic D Rotz S Shreenivas A Steinberg A Tabbara K Tichelli A Wirk B Yared J Basak GW Battiwalla M Duarte R Savani BN Flowers MED Shaw BE Valdés-Sanz N Non-Graft-versus-Host Disease Ocular Complications after Hematopoietic Cell Transplantation: Expert Review from the Late Effects and Quality of Life Working Committee of the Center for International Blood and Marrow Transplant Research and the Transplant Complications Working Party of the European Society for Blood and Marrow Transplantation. Biol Blood Marrow Transplant . 2018 Dec 3;
[PubMed ID: 30521975]
Brunstein CG Pasquini MC Kim S Fei M Adekola K Ahmed I Aljurf M Agrawal V Auletta JJ Battiwalla M Bejanyan N Bubalo J Cerny J Chee L Ciurea SO Freytes C Gadalla SM Gale RP Ganguly S Hashmi SK Hematti P Hildebrandt G Holmberg LA Lahoud OB Landau H Lazarus HM de Lima M Mathews V Maziarz R Nishihori T Norkin M Olsson R Reshef R Rotz S Savani B Schouten HC Seo S Wirk BM Yared J Mineishi S Rogosheske J Perales MA Effect of Conditioning Regimen Dose Reduction in Obese Patients Undergoing Autologous Hematopoietic Cell Transplantation. Biol Blood Marrow Transplant . 2018 Nov 10;
[PubMed ID: 30423481]
Radivoyevitch T Dean RM Shaw BE Brazauskas R Tecca HR Molenaar RJ Battiwalla M Savani BN Flowers MED Cooke KR Hamilton BK Kalaycio M Maciejewski JP Ahmed I Akpek G Bajel A Buchbinder D Cahn JY D'Souza A Daly A DeFilipp Z Ganguly S Hamadani M Hayashi RJ Hematti P Inamoto Y Khera N Kindwall-Keller T Landau H Lazarus H Majhail NS Marks DI Olsson RF Seo S Steinberg A William BM Wirk B Yared JA Aljurf M Abidi MH Allewelt H Beitinjaneh A Cook R Cornell RF Fay JW Hale G Chakrabarty JH Jodele S Kasow KA Mahindra A Malone AK Popat U Rizzo JD Schouten HC Warwick AB Wood WA Sekeres MA Litzow MR Gale RP Hashmi SK Risk of acute myeloid leukemia and myelodysplastic syndrome after autotransplants for lymphomas and plasma cell myeloma. Leuk Res . 2018 Nov;74:130-136
[PubMed ID: 30055822]
Samaeekia R Rabiee B Putra I Shen X Park YJ Hematti P Eslani M Djalilian AR Effect of Human Corneal Mesenchymal Stromal Cell-derived Exosomes on Corneal Epithelial Wound Healing. Invest Ophthalmol Vis Sci . 2018 Oct 1;59(12):5194-5200
[PubMed ID: 30372747]
Braun RK Chetty C Balasubramaniam V Centanni R Haraldsdottir K Hematti P Eldridge MW Intraperitoneal injection of MSC-derived exosomes prevent experimental bronchopulmonary dysplasia. Biochem Biophys Res Commun . 2018 Sep 18;503(4):2653-2658
[PubMed ID: 30093115]
Tanimura N Liao R Wilson GM Dent MR Cao M Burstyn JN Hematti P Liu X Zhang Y Zheng Y Keles S Xu J Coon JJ Bresnick EH GATA/Heme Multi-omics Reveals a Trace Metal-Dependent Cellular Differentiation Mechanism. Dev Cell . 2018 Sep 10;46(5):581-594.e4
[PubMed ID: 30122630]
Sahasrabudhe K Otto M Hematti P Kenkre V TCR αβ+/CD19+ cell depletion in haploidentical hematopoietic allogeneic stem cell transplantation: a review of current data. Leuk Lymphoma . 2018 Sep 6;:1-12
[PubMed ID: 30187806]
Turcotte LM Wang T Hemmer MT Spellman SR Arora M Couriel D Alousi A Pidala J Abdel-Azim H Ahmed I Beitinjaneh A Buchbinder D Byrne M Callander N Chao N Choi SW DeFilipp Z Gadalla SM Gale RP Gergis U Hashmi S Hematti P Holmberg L Inamoto Y Kamble RT Lehmann L MacMillan MA McIver Z Nishihori T Norkin M O'Brien T Olsson RF Reshef R Saad A Savani BN Schouten HC Seo S Solh M Verdonck L Vij R Wirk B Yared J Horowitz MM Knight JM Verneris MR Donor body mass index does not predict graft versus host disease following hematopoietic cell transplantation. Bone Marrow Transplant . 2018 Jul;53(7):932-937
[PubMed ID: 29382954]
Bloom DD Reshetylo S Nytes C Goodsett CT Hematti P Blockade of BAFF Receptor BR3 on T Cells Enhances Their Activation and Cytotoxicity. J Immunother . 2018 Jun;41(5):213-223
[PubMed ID: 29309290]
Eslani M Putra I Shen X Hamouie J Tadepalli A Anwar KN Kink JA Ghassemi S Agnihotri G Reshetylo S Mashaghi A Dana R Hematti P Djalilian AR Cornea-Derived Mesenchymal Stromal Cells Therapeutically Modulate Macrophage Immunophenotype and Angiogenic Function. Stem Cells . 2018 May;36(5):775-784
[PubMed ID: 29341332]
Qayed M Wang T Hemmer MT Spellman S Arora M Couriel D Alousi A Pidala J Abdel-Azim H Aljurf M Ayas M Bitan M Cairo M Choi SW Dandoy C Delgado D Gale RP Hale G Frangoul H Kamble RT Kharfan-Dabaja M Lehman L Levine J MacMillan M Marks DI Nishihori T Olsson RF Hematti P Ringden O Saad A Satwani P Savani BN Schultz KR Seo S Shenoy S Waller EK Yu L Horowitz MM Horan J Influence of Age on Acute and Chronic GVHD in Children Undergoing HLA-Identical Sibling Bone Marrow Transplantation for Acute Leukemia: Implications for Prophylaxis. Biol Blood Marrow Transplant . 2018 Mar;24(3):521-528
[PubMed ID: 29155316]
Huynh M Pak C Markovina S Callander NS Chng KS Wuerzberger-Davis SM Bakshi DD Kink JA Hematti P Hope C Asimakopoulos F Rui L Miyamoto S Hyaluronan and proteoglycan link protein 1 (HAPLN1) activates bortezomib-resistant NF-κB activity and increases drug resistance in multiple myeloma. J Biol Chem . 2018 Feb 16;293(7):2452-2465
[PubMed ID: 29279332]